Programme Titles Presenters
Sunday, 3 November 2013
11:00-13:00 Registration
13:00-13:15 Welcome and Introduction
13:15-14:00 Achieving an AIDS-free World: Scientific Advances and Public Health Implementation
Session 1: Targeting the Reservoirs & Working Towards a Cure
14:00-14:05 Setting the Scene
14:05-14:30 HIV Latency: A Drug Discovery Perspective
14:30-14:55 Early Development and Testing of Tools for Cure
14:55-15:20 A New Potential Approach for Attacking the Latent HIV Reservoir
15:20-15:50 Refreshment Break
15:50-16:15 Measurement and Mechanism of HIV Persistence: Challenges of Retroviral Biology
16:15-16:40 Potential Role of Graft-Versus-Host Reaction in Reducing the HIV-1 Reservoir
16:40-17:25 Panel Discussion: Which of these suggested routes to a cure are most feasible to pursue?
17:25-17:55 Oral Poster Session 1
17:55-19:10 Drinks Reception & Poster Session
Monday, 4 November 2013
Session 2: Vaccines & Harnessing the Immune Response
08.00-08:05 Setting the Scene
08.05-08:30 Preventing the Spread of HIV with Antibody Genes
08:30-08:55 Toward an HIV Vaccine: What Can the Virus Reveal?
08:55-09:20 Human Antibodies to HIV in Vaccine Development and Therapy
09:20-09:50 Refreshment Break
09:50-10:15 Strategies for HIV Vaccine Design
10.15-10:40 TBA
10:40-11:25 Panel Discussion: What kind of host immune response do we need to generate to have an effective vaccine?
11:25-11:55 Oral Poster Session 2
11:55-12:55 Lunch
Session 3: Antiretrovirals for Primary & Secondary HIV Prevention
13:00-13:05 Setting the Scene
13:05-13:25 Antiretroviral Treatment of HIV-1 Prevents Transmission of HIV-1: Where Do We Go From Here?
13:25-13:45 ART for Prevention: Key Unanswered Questions
13:45-14:05 What Will It Take To Achieve an AIDS-Free Generation in Uganda?
14:05-14:50 Panel Discussion: Test and treat as a global strategy
14:50-15:20 Refreshment Break
15:20-15:40 PrEP: Evidence, Questions, and Implementation Priorities
15:40-16:00 Making Pharmacological Sense of the Successes and Failures Among PrEP Clinical Trials
16:00-16:20 Hormonal Contraception and HIV Acquisition and Prevention
16:20-17:05 Panel Discussion: Chemoprophylaxis
17:05-17:35 Debate: How to prevent epidemics worldwide?
19:30 Meet the Speakers Dinner – Ticket holders only
After Dinner - Speaker: T. Brown, Timothy Ray Brown Foundation of the World AIDS Institute, USA
Tuesday, 5 November 2013
Session 4: Long Term Consequences of Living with HIV: Comorbidities & Aging
08.00-08:05 Setting the Scene
08.05-08:30 The End of AIDS: HIV Infection as a Chronic Disease
08:30-08:55 Differences in Pathogen-Specific T cell Susceptibility to HIV Influence the Natural History of Opportunistic Infections
08:55-09:20 Risk of Serious Disease and Death in People with HIV Viral Suppression on ART: An Epidemiologic Perspective
09:20-09:45 HIV and Aging: Challenges for Prevention and Case Management
09:45-10:10 TBA
10.10-10:40 Refreshment Break
10:40-11:05 HIV-Associated Neurocognitive Disorder in the cART Era
11:05-11:30 Long Term Impact of Antiretroviral Therapy in Resource Limited Settings
11:30-12:15 Panel Discussion: What’s the biggest risk for long term survivors of HIV?
12:15-13:15 Lunch
13:15-14:45 Session 5: Challenge Discussion: What Will It Take to Achieve an AIDS-Free World?
14:45-15:15 Refreshment Break
15:15-15:40 Conference Summing Up
15:40-16:00 Closing Remarks
Registration handled on behalf of Elsevier Ltd by Oxford Abstracts
Copyright 2018 Elsevier Limited. Privacy | Terms | Cookies
Oxford Abstracts. Privacy | Terms | Cookies